This session features Olivera Finn (University of Pittsburgh School of Medicine) presenting on "Vaccines for prevention of non-viral cancers," Malte Roerden (Koch Institute postdoc in the Spranger Lab) presenting on "Leveraging antigen architectures to maximize anti-tumor immunity," and Peter DeMuth (Elicio Therapeutics) presenting on "Targeting the lymph nodes to orchestrate anti-tumor immunity."
12 июл 2023
